NBTXR3 and Radiation Therapy for the Treatment of Inoperable Recurrent Non-small Cell Lung Cancer

Recruiting

Phase 1

NBTXR3 and Radiation Therapy for the Treatment of Inoperable Recurrent Non-small Cell Lung Cancer

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT04505267

Conditions

Recurrent Lung Non-Small Cell Carcinoma

Stage I Lung Cancer AJCC v8

Stage IA1 Lung Cancer AJCC v8

Stage IA2 Lung Cancer AJCC v8

Stage IA3 Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Hafnium Oxide-containing Nanoparticles NBTXR3

Radiation Therapy

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-05. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2025-05-20.